CD274 and cancer: For example, pemetrexed promotes immune checkpoint blockade through per se undesired transcriptional activation of PD-L1 in cancer cells, and activation of T-lymphocytes was observed in vitro when pemetrexed was combined with the anti-PD-1/PD-L1 therapy (245).